Bellevue Group’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $149M | Buy |
|
|||||
|
2025
Q2 | $119M | Buy |
|
|||||
|
2025
Q1 | $103M | Hold |
|
|||||
|
2024
Q4 | $116M | Sell |
|
|||||
|
2024
Q3 | $166M | Sell |
|
|||||
|
2024
Q2 | $167M | Sell |
|
|||||
|
2024
Q1 | $117M | Sell |
|
|||||
|
2023
Q4 | $89.3M | Sell |
|
|||||
|
2023
Q3 | $99.3M | Hold |
|
|||||
|
2023
Q2 | $114M | Hold |
|
|||||
|
2023
Q1 | $92.2M | Sell |
|
|||||
|
2022
Q4 | $114M | Sell |
|
|||||
|
2022
Q3 | $115M | Sell |
|
|||||
|
2022
Q2 | $90.1M | Sell |
|
|||||
|
2022
Q1 | $120M | Sell |
|
|||||
|
2021
Q4 | $143M | Buy |
|
|||||
|
2021
Q3 | $200M | Sell |
|
|||||
|
2021
Q2 | $240M | Sell |
|
|||||
|
2021
Q1 | $234M | Buy |
|
|||||
|
2020
Q4 | $182M | Buy |
|
|||||
|
2020
Q3 | $145M | Buy |
|
|||||
|
2020
Q2 | $215M | Buy |
|
|||||
|
2020
Q1 | $139M | Sell |
|
|||||
|
2019
Q4 | $187M | Buy |
|
|||||
|
2019
Q3 | $116M | Buy |
|
|||||
|
2019
Q2 | $156M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $1.53M | Sell |
|
|||||
|
2018
Q2 | $2.43M | Sell |
|
|||||
|
2018
Q1 | $3.3M | Sell |
|
|||||
|
2017
Q4 | $2.34M | Sell |
|
|||||
|
2017
Q3 | $3M | Hold |
|
|||||
|
2017
Q2 | $2.31M | Hold |
|
|||||
|
2017
Q1 | $2.63M | Hold |
|
|||||
|
2016
Q4 | $1.88M | Hold |
|
|||||
|
2016
Q3 | $2.38M | Buy |
|
|||||
|
2016
Q2 | $1.51M | Sell |
|
|||||
|
2016
Q1 | $2.19M | Buy |
|